Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust.
In March 2003, an international mulltidisciplinary group of scientists and clinicians with a specific interest in ovarian cancer met for 4 days to discuss research into and treatment of this challenging disease. Under the headings of molecular genetics, molecular biology, the biology of ovarian cancer, old therapies, new targets and the early detection of the disease, this Position Paper summarises the presentations and discussion from the 9th Biennial Helene Harris Memorial Trust Forum on Ovarian Cancer. In particular, we highlight the potential of international collaborations in translating laboratory science into useful clinical interventions.
Balkwill
F
F
Cancer Research UK, Queen Mary's School of Medicine and Dentistry, EC1M 6BQ London, UK. frances.balkwill@cancer.org.uk
Bast
R C
RC
Berek
J
J
Chenevix-Trench
G
G
Gore
M
M
Hamilton
T
T
Jacobs
I
I
Mills
G
G
Souhami
R
R
Urban
N
N
Orsulic
S
S
Smyth
J
J
Ursulic
S
S
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D005260:Female; D005544:Forecasting; D015870:Gene Expression; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D016147:Genes, Tumor Suppressor; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009154:Mutation / Q000235:genetics; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor